Abstract
Get full access to this article
View all access options for this article.
References
1.Global Initiative for Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management and prevention of COPD: revised 2011 . http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf. Accessed November 28, 2012 .
2.
Sonetti
DA
Hospenthal
AC
Adams
SG.
Integrated management strategies for chronic obstructive pulmonary disease . J Multidiscip Healthc . 2010 ;3 :181 -188 .
3.Centers for Disease Control and Prevention . Chronic obstructive pulmonary disease . www.cdc.gov/COPD. Accessed December 21, 2012 .
4.Centers for Disease Control and Prevention . Asthma’s impact on the nation . www.cdc.gov/asthma/. Accessed December 21, 2012 .
5.
Dweik
RA
. Role of anticholinergic therapy in COPD . http://www.uptodate.com/contents/role-of-anticholinergic-therapy-in-copd. Accessed November 29, 2012 .
6.
Aaron
S
. Anticholinergic agents in the management of acute exacerbations of asthma . http://www.uptodate.com/contents/anticholinergic-agents-in-the-management-of-acute-exacerbations-of-asthma. Accessed November 29, 2012 .
7.Combivent (ipratropium bromide and albuterol sulfate) Inhalation Aerosol [package insert] . Ridgefield, CT : Boehringer Ingelheim Pharmaceuticals, Inc ; 2012 .
8.DuoNeb (ipratropium bromide and albuterol sulfate) Inhalation Solution [package insert] . Napa, CA : Dey Pharma LP ; 2012 .
9.
Ogbru
O
. Albuterol and ipratropium inhaler, Combivent, Combivent Respimat . http://www.medicinenet.com/albuterol_and_ipratropium_inhaler/article.htm. Accessed November 29, 2012 .
10.
Edmunds
MW
Mayhew
MS
. Pharmacology for the Primary Care Provider . 3rd ed. St Louis, MA : Mosby ; 2009 :192 .